Methylene Blue
Methylene blue is a synthetic phenothiazine dye and old repurposed drug — FDA-approved for methemoglobinemia — that is also studied at low doses for potential mitochondrial and cognitive effects, though robust human evidence for cognitive enhancement in healthy people remains limited.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
What it does & how it works
Methylene blue is a redox-active phenothiazine compound that can accept and donate electrons, allowing it to act as an alternative electron carrier within the mitochondrial electron transport chain, particularly when complex I or complex III activity is impaired. By facilitating electron transfer to cytochrome c oxidase (complex IV), it can help preserve mitochondrial ATP production and reduce markers of oxidative stress in preclinical models of mitochondrial dysfunction. Separately, at low concentrations it inhibits monoamine oxidase and affects nitric oxide/cyclic GMP signaling, mechanisms considered relevant to its historical psychiatric and antimalarial uses.
Typical results seen in research
In rodent models of chronic cerebral hypoperfusion and related neurodegenerative-disease models, low-dose methylene blue preserved mitochondrial cytochrome oxidase activity and reduced measures of cognitive and memory impairment. Human evidence for cognitive enhancement in healthy people is limited and comes mainly from small, older studies using memory-task paradigms; its long-established, well-supported human use remains as the antidote for methemoglobinemia and as a surgical/diagnostic dye, not as a validated cognitive-enhancement or longevity therapy.
How it’s commonly used
Methylene blue is administered clinically by intravenous injection for its approved use (methemoglobinemia), and is taken orally in research and off-label contexts exploring mitochondrial or cognitive effects. It is not approved for any weight-loss, longevity, or cognitive-enhancement indication, and use for those purposes occurs only in research or self-directed contexts outside standard medical protocols; it also carries known drug-interaction risks — notably serotonin syndrome when combined with serotonergic medications — that limit who can safely use it.
- Journal of Biological Chemistry · 2011 Alternative mitochondrial electron transfer as a novel strategy for neuroprotection
- Journal of Alzheimer's Disease · 2014 Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion
- Molecular Neurobiology · 2016 Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model
Curated from published literature for research orientation. Not an exhaustive review, and not a substitute for reading primary sources.